nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—lung cancer	0.329	1	CiPCiCtD
Capecitabine—TYMS—lung cancer	0.121	1	CbGaD
Capecitabine—esophageal cancer—lung cancer	0.111	0.422	CtDrD
Capecitabine—colon cancer—lung cancer	0.0925	0.353	CtDrD
Capecitabine—TYMS—Pemetrexed—lung cancer	0.0671	0.366	CbGbCtD
Capecitabine—kidney cancer—lung cancer	0.0587	0.224	CtDrD
Capecitabine—CDA—Gemcitabine—lung cancer	0.0542	0.296	CbGbCtD
Capecitabine—TYMS—Gemcitabine—lung cancer	0.0241	0.132	CbGbCtD
Capecitabine—CES1—Irinotecan—lung cancer	0.0168	0.0917	CbGbCtD
Capecitabine—TYMS—Methotrexate—lung cancer	0.0114	0.0622	CbGbCtD
Capecitabine—CYP2C9—Gefitinib—lung cancer	0.00319	0.0174	CbGbCtD
Capecitabine—CYP2C9—Teniposide—lung cancer	0.00309	0.0169	CbGbCtD
Capecitabine—CYP2C9—Paclitaxel—lung cancer	0.00173	0.00943	CbGbCtD
Capecitabine—DPYD—mammary gland—lung cancer	0.00142	0.126	CbGeAlD
Capecitabine—CYP2C9—Cisplatin—lung cancer	0.00139	0.00759	CbGbCtD
Capecitabine—TYMP—mammary gland—lung cancer	0.000823	0.0728	CbGeAlD
Capecitabine—DPYD—bronchus—lung cancer	0.000779	0.0689	CbGeAlD
Capecitabine—DPYD—cardiac atrium—lung cancer	0.000657	0.0581	CbGeAlD
Capecitabine—DPYD—bone marrow—lung cancer	0.000554	0.0491	CbGeAlD
Capecitabine—TYMP—respiratory system—lung cancer	0.000548	0.0485	CbGeAlD
Capecitabine—CDA—bone marrow—lung cancer	0.000533	0.0472	CbGeAlD
Capecitabine—DPYD—lung—lung cancer	0.000502	0.0445	CbGeAlD
Capecitabine—CES1—respiratory system—lung cancer	0.000473	0.0419	CbGeAlD
Capecitabine—TYMS—respiratory system—lung cancer	0.00047	0.0416	CbGeAlD
Capecitabine—TYMP—bronchus—lung cancer	0.000451	0.0399	CbGeAlD
Capecitabine—TYMP—trachea—lung cancer	0.000405	0.0359	CbGeAlD
Capecitabine—TYMS—bronchus—lung cancer	0.000387	0.0343	CbGeAlD
Capecitabine—TYMP—cardiac atrium—lung cancer	0.000381	0.0337	CbGeAlD
Capecitabine—DPYD—lymph node—lung cancer	0.000344	0.0304	CbGeAlD
Capecitabine—CDA—lymph node—lung cancer	0.000331	0.0293	CbGeAlD
Capecitabine—TYMP—bone marrow—lung cancer	0.000321	0.0284	CbGeAlD
Capecitabine—CYP2C9—mammary gland—lung cancer	0.000308	0.0273	CbGeAlD
Capecitabine—TYMP—lung—lung cancer	0.000291	0.0258	CbGeAlD
Capecitabine—TYMS—bone marrow—lung cancer	0.000276	0.0244	CbGeAlD
Capecitabine—CES1—lung—lung cancer	0.000251	0.0222	CbGeAlD
Capecitabine—TYMS—lung—lung cancer	0.00025	0.0221	CbGeAlD
Capecitabine—TYMP—lymph node—lung cancer	0.000199	0.0176	CbGeAlD
Capecitabine—TYMS—Docetaxel—Paclitaxel—lung cancer	0.000196	0.185	CbGdCrCtD
Capecitabine—CES1—lymph node—lung cancer	0.000172	0.0152	CbGeAlD
Capecitabine—TYMS—lymph node—lung cancer	0.000171	0.0151	CbGeAlD
Capecitabine—TYMS—Erlotinib—Gefitinib—lung cancer	0.000146	0.138	CbGdCrCtD
Capecitabine—TYMS—Podofilox—Teniposide—lung cancer	0.000106	0.0995	CbGdCrCtD
Capecitabine—TYMS—Paclitaxel—Docetaxel—lung cancer	9.79e-05	0.0922	CbGdCrCtD
Capecitabine—TYMS—Afatinib—Gefitinib—lung cancer	9.57e-05	0.0902	CbGdCrCtD
Capecitabine—TYMS—Gefitinib—Erlotinib—lung cancer	9.39e-05	0.0884	CbGdCrCtD
Capecitabine—TYMS—Vincristine—Vinorelbine—lung cancer	6.73e-05	0.0634	CbGdCrCtD
Capecitabine—TYMS—Vinorelbine—Vinblastine—lung cancer	6.29e-05	0.0592	CbGdCrCtD
Capecitabine—TYMS—Podofilox—Etoposide—lung cancer	6.28e-05	0.0592	CbGdCrCtD
Capecitabine—TYMS—Vinblastine—Vinorelbine—lung cancer	5.41e-05	0.0509	CbGdCrCtD
Capecitabine—TYMS—Vincristine—Vinblastine—lung cancer	5.38e-05	0.0506	CbGdCrCtD
Capecitabine—TYMS—Azacitidine—Gemcitabine—lung cancer	2.53e-05	0.0239	CbGdCrCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	1.39e-05	0.000495	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.38e-05	0.000493	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPP2R1B—lung cancer	1.38e-05	0.000493	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CKB—lung cancer	1.38e-05	0.000493	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.38e-05	0.000491	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.36e-05	0.000486	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTT1—lung cancer	1.35e-05	0.000481	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP2A6—lung cancer	1.33e-05	0.000476	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GCLC—lung cancer	1.33e-05	0.000476	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.33e-05	0.000475	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	1.32e-05	0.000472	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTP1—lung cancer	1.31e-05	0.000468	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTM2—lung cancer	1.3e-05	0.000463	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CNDP2—lung cancer	1.3e-05	0.000463	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CAT—lung cancer	1.28e-05	0.000455	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—lung cancer	1.27e-05	0.000455	CbGpPWpGaD
Capecitabine—CDA—Metabolism—STK11—lung cancer	1.26e-05	0.000451	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ENO1—lung cancer	1.26e-05	0.000451	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTMR3—lung cancer	1.26e-05	0.000451	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ABCB1—lung cancer	1.24e-05	0.000443	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.24e-05	0.000441	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PGAM1—lung cancer	1.23e-05	0.000439	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TYMS—lung cancer	1.22e-05	0.000435	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	1.22e-05	0.000434	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTM1—lung cancer	1.21e-05	0.00043	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.2e-05	0.000429	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.2e-05	0.000429	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—HPGDS—lung cancer	1.2e-05	0.000428	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP2A7—lung cancer	1.17e-05	0.000419	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTP1—lung cancer	1.17e-05	0.000417	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.16e-05	0.000415	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTT1—lung cancer	1.16e-05	0.000415	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.16e-05	0.000414	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—JUN—lung cancer	1.15e-05	0.000411	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GCLC—lung cancer	1.15e-05	0.00041	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP2A6—lung cancer	1.15e-05	0.00041	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SDC4—lung cancer	1.15e-05	0.00041	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP1A1—lung cancer	1.14e-05	0.000408	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CAT—lung cancer	1.14e-05	0.000406	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ERCC2—lung cancer	1.13e-05	0.000404	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP2E1—lung cancer	1.13e-05	0.000404	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—lung cancer	1.12e-05	0.0004	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NQO1—lung cancer	1.12e-05	0.0004	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PTEN—lung cancer	1.12e-05	0.000398	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.11e-05	0.000395	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ABCB1—lung cancer	1.11e-05	0.000395	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TYMS—lung cancer	1.09e-05	0.000388	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.08e-05	0.000384	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTM1—lung cancer	1.07e-05	0.000383	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—EP300—lung cancer	1.06e-05	0.000379	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	1.05e-05	0.000375	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.05e-05	0.000374	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—RRM1—lung cancer	1.05e-05	0.000373	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTA3—lung cancer	1.05e-05	0.000373	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—BIRC5—lung cancer	1.04e-05	0.000371	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP1A1—lung cancer	1.02e-05	0.000363	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ERCC2—lung cancer	1.01e-05	0.00036	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—STK11—lung cancer	1.01e-05	0.00036	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	9.93e-06	0.000354	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—lung cancer	9.86e-06	0.000352	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—B4GALT5—lung cancer	9.84e-06	0.000351	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—APOA1—lung cancer	9.81e-06	0.00035	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP2E1—lung cancer	9.78e-06	0.000349	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	9.66e-06	0.000344	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP2E1—lung cancer	9.64e-06	0.000344	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTA4—lung cancer	9.57e-06	0.000341	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	9.45e-06	0.000337	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTP1—lung cancer	9.35e-06	0.000334	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTA2—lung cancer	9.33e-06	0.000333	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—BIRC5—lung cancer	9.31e-06	0.000332	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CAT—lung cancer	9.1e-06	0.000325	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TERT—lung cancer	9.02e-06	0.000322	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTA1—lung cancer	9e-06	0.000321	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CG—lung cancer	8.96e-06	0.000319	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	8.92e-06	0.000318	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCC3—lung cancer	8.9e-06	0.000317	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ABCB1—lung cancer	8.85e-06	0.000316	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APOA1—lung cancer	8.74e-06	0.000312	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—TYMS—lung cancer	8.69e-06	0.00031	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKR1C1—lung cancer	8.62e-06	0.000307	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTM1—lung cancer	8.59e-06	0.000306	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—POMC—lung cancer	8.52e-06	0.000304	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—UGT1A1—lung cancer	8.37e-06	0.000298	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CREBBP—lung cancer	8.3e-06	0.000296	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	8.2e-06	0.000292	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	8.18e-06	0.000292	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP1A1—lung cancer	8.15e-06	0.000291	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ERCC2—lung cancer	8.08e-06	0.000288	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GNG11—lung cancer	8.07e-06	0.000288	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTP1—lung cancer	8.06e-06	0.000288	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CG—lung cancer	7.98e-06	0.000285	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTP1—lung cancer	7.95e-06	0.000284	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	7.93e-06	0.000283	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CD—lung cancer	7.87e-06	0.000281	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—RB1—lung cancer	7.85e-06	0.00028	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ALB—lung cancer	7.77e-06	0.000277	CbGpPWpGaD
Capecitabine—Pain—Paclitaxel—lung cancer	7.76e-06	0.00012	CcSEcCtD
Capecitabine—Confusional state—Docetaxel—lung cancer	7.76e-06	0.00012	CcSEcCtD
Capecitabine—Pharyngitis—Methotrexate—lung cancer	7.74e-06	0.000119	CcSEcCtD
Capecitabine—Urinary tract disorder—Methotrexate—lung cancer	7.71e-06	0.000119	CcSEcCtD
Capecitabine—Photosensitivity reaction—Doxorubicin—lung cancer	7.7e-06	0.000119	CcSEcCtD
Capecitabine—Oedema—Docetaxel—lung cancer	7.69e-06	0.000119	CcSEcCtD
Capecitabine—TYMS—Metabolism—ALDOA—lung cancer	7.68e-06	0.000274	CbGpPWpGaD
Capecitabine—Weight increased—Doxorubicin—lung cancer	7.68e-06	0.000119	CcSEcCtD
Capecitabine—Pruritus—Gemcitabine—lung cancer	7.67e-06	0.000118	CcSEcCtD
Capecitabine—Urethral disorder—Methotrexate—lung cancer	7.65e-06	0.000118	CcSEcCtD
Capecitabine—Infection—Docetaxel—lung cancer	7.64e-06	0.000118	CcSEcCtD
Capecitabine—Weight decreased—Doxorubicin—lung cancer	7.64e-06	0.000118	CcSEcCtD
Capecitabine—Feeling abnormal—Etoposide—lung cancer	7.63e-06	0.000118	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—TP53—lung cancer	7.61e-06	0.000272	CbGpPWpGaD
Capecitabine—Hyperglycaemia—Doxorubicin—lung cancer	7.61e-06	0.000117	CcSEcCtD
Capecitabine—Diarrhoea—Irinotecan—lung cancer	7.61e-06	0.000117	CcSEcCtD
Capecitabine—CDA—Metabolism—POMC—lung cancer	7.6e-06	0.000271	CbGpPWpGaD
Capecitabine—Pneumonia—Doxorubicin—lung cancer	7.57e-06	0.000117	CcSEcCtD
Capecitabine—Gastrointestinal pain—Etoposide—lung cancer	7.57e-06	0.000117	CcSEcCtD
Capecitabine—Shock—Docetaxel—lung cancer	7.57e-06	0.000117	CcSEcCtD
Capecitabine—Nervous system disorder—Docetaxel—lung cancer	7.54e-06	0.000116	CcSEcCtD
Capecitabine—Thrombocytopenia—Docetaxel—lung cancer	7.53e-06	0.000116	CcSEcCtD
Capecitabine—Infestation—Doxorubicin—lung cancer	7.53e-06	0.000116	CcSEcCtD
Capecitabine—Infestation NOS—Doxorubicin—lung cancer	7.53e-06	0.000116	CcSEcCtD
Capecitabine—Visual impairment—Methotrexate—lung cancer	7.52e-06	0.000116	CcSEcCtD
Capecitabine—Tachycardia—Docetaxel—lung cancer	7.51e-06	0.000116	CcSEcCtD
Capecitabine—Feeling abnormal—Paclitaxel—lung cancer	7.48e-06	0.000115	CcSEcCtD
Capecitabine—Skin disorder—Docetaxel—lung cancer	7.47e-06	0.000115	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	7.46e-06	0.000115	CcSEcCtD
Capecitabine—TYMS—Metabolism—NCOA3—lung cancer	7.46e-06	0.000266	CbGpPWpGaD
Capecitabine—Hypersensitivity—Cisplatin—lung cancer	7.44e-06	0.000115	CcSEcCtD
Capecitabine—Gastrointestinal pain—Paclitaxel—lung cancer	7.42e-06	0.000114	CcSEcCtD
Capecitabine—Diarrhoea—Gemcitabine—lung cancer	7.42e-06	0.000114	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—lung cancer	7.41e-06	0.000264	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CREBBP—lung cancer	7.4e-06	0.000264	CbGpPWpGaD
Capecitabine—Renal failure—Doxorubicin—lung cancer	7.4e-06	0.000114	CcSEcCtD
Capecitabine—Erythema multiforme—Methotrexate—lung cancer	7.38e-06	0.000114	CcSEcCtD
Capecitabine—Neuropathy peripheral—Doxorubicin—lung cancer	7.38e-06	0.000114	CcSEcCtD
Capecitabine—Dizziness—Irinotecan—lung cancer	7.36e-06	0.000114	CcSEcCtD
Capecitabine—Urticaria—Etoposide—lung cancer	7.35e-06	0.000113	CcSEcCtD
Capecitabine—Stomatitis—Doxorubicin—lung cancer	7.34e-06	0.000113	CcSEcCtD
Capecitabine—Jaundice—Doxorubicin—lung cancer	7.34e-06	0.000113	CcSEcCtD
Capecitabine—Anorexia—Docetaxel—lung cancer	7.33e-06	0.000113	CcSEcCtD
Capecitabine—Abdominal pain—Etoposide—lung cancer	7.32e-06	0.000113	CcSEcCtD
Capecitabine—Body temperature increased—Etoposide—lung cancer	7.32e-06	0.000113	CcSEcCtD
Capecitabine—Conjunctivitis—Doxorubicin—lung cancer	7.32e-06	0.000113	CcSEcCtD
Capecitabine—Urinary tract infection—Doxorubicin—lung cancer	7.32e-06	0.000113	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—lung cancer	7.31e-06	0.000261	CbGpPWpGaD
Capecitabine—Eye disorder—Methotrexate—lung cancer	7.29e-06	0.000112	CcSEcCtD
Capecitabine—Tinnitus—Methotrexate—lung cancer	7.28e-06	0.000112	CcSEcCtD
Capecitabine—TYMS—Metabolism—ADCY1—lung cancer	7.26e-06	0.000259	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCG2—lung cancer	7.26e-06	0.000259	CbGpPWpGaD
Capecitabine—Asthenia—Cisplatin—lung cancer	7.25e-06	0.000112	CcSEcCtD
Capecitabine—Cardiac disorder—Methotrexate—lung cancer	7.24e-06	0.000112	CcSEcCtD
Capecitabine—Urticaria—Paclitaxel—lung cancer	7.21e-06	0.000111	CcSEcCtD
Capecitabine—Hypotension—Docetaxel—lung cancer	7.19e-06	0.000111	CcSEcCtD
Capecitabine—Haematuria—Doxorubicin—lung cancer	7.18e-06	0.000111	CcSEcCtD
Capecitabine—Abdominal pain—Paclitaxel—lung cancer	7.17e-06	0.000111	CcSEcCtD
Capecitabine—Body temperature increased—Paclitaxel—lung cancer	7.17e-06	0.000111	CcSEcCtD
Capecitabine—Hepatobiliary disease—Doxorubicin—lung cancer	7.12e-06	0.00011	CcSEcCtD
Capecitabine—TYMS—Metabolism—ENO2—lung cancer	7.12e-06	0.000254	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HPGDS—lung cancer	7.12e-06	0.000254	CbGpPWpGaD
Capecitabine—Epistaxis—Doxorubicin—lung cancer	7.1e-06	0.00011	CcSEcCtD
Capecitabine—Angiopathy—Methotrexate—lung cancer	7.08e-06	0.000109	CcSEcCtD
Capecitabine—Vomiting—Irinotecan—lung cancer	7.07e-06	0.000109	CcSEcCtD
Capecitabine—TYMS—Metabolism—PPP2R1B—lung cancer	7.07e-06	0.000252	CbGpPWpGaD
Capecitabine—Immune system disorder—Methotrexate—lung cancer	7.05e-06	0.000109	CcSEcCtD
Capecitabine—Mediastinal disorder—Methotrexate—lung cancer	7.03e-06	0.000108	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—CYP1A1—lung cancer	7.02e-06	0.000251	CbGpPWpGaD
Capecitabine—Agranulocytosis—Doxorubicin—lung cancer	7.02e-06	0.000108	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—RB1—lung cancer	7.02e-06	0.00025	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CD—lung cancer	7.02e-06	0.00025	CbGpPWpGaD
Capecitabine—Rash—Irinotecan—lung cancer	7.02e-06	0.000108	CcSEcCtD
Capecitabine—Dermatitis—Irinotecan—lung cancer	7.01e-06	0.000108	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Docetaxel—lung cancer	7.01e-06	0.000108	CcSEcCtD
Capecitabine—Chills—Methotrexate—lung cancer	7e-06	0.000108	CcSEcCtD
Capecitabine—TYMP—Metabolism—APOA1—lung cancer	6.99e-06	0.000249	CbGpPWpGaD
Capecitabine—Headache—Irinotecan—lung cancer	6.97e-06	0.000108	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—IL6—lung cancer	6.97e-06	0.000249	CbGpPWpGaD
Capecitabine—Insomnia—Docetaxel—lung cancer	6.96e-06	0.000107	CcSEcCtD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1A1—lung cancer	6.93e-06	0.000247	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—lung cancer	6.93e-06	0.000247	CbGpPWpGaD
Capecitabine—Diarrhoea—Cisplatin—lung cancer	6.91e-06	0.000107	CcSEcCtD
Capecitabine—Paraesthesia—Docetaxel—lung cancer	6.91e-06	0.000107	CcSEcCtD
Capecitabine—TYMS—Metabolism—GSTT1—lung cancer	6.9e-06	0.000246	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—lung cancer	6.9e-06	0.000246	CbGpPWpGaD
Capecitabine—Alopecia—Methotrexate—lung cancer	6.89e-06	0.000106	CcSEcCtD
Capecitabine—Vomiting—Gemcitabine—lung cancer	6.89e-06	0.000106	CcSEcCtD
Capecitabine—Bradycardia—Doxorubicin—lung cancer	6.88e-06	0.000106	CcSEcCtD
Capecitabine—DPYD—Metabolism—PIK3CB—lung cancer	6.86e-06	0.000245	CbGpPWpGaD
Capecitabine—Dyspnoea—Docetaxel—lung cancer	6.86e-06	0.000106	CcSEcCtD
Capecitabine—Mental disorder—Methotrexate—lung cancer	6.84e-06	0.000105	CcSEcCtD
Capecitabine—Rash—Gemcitabine—lung cancer	6.83e-06	0.000105	CcSEcCtD
Capecitabine—Dermatitis—Gemcitabine—lung cancer	6.83e-06	0.000105	CcSEcCtD
Capecitabine—TYMS—Metabolism—CYP2A6—lung cancer	6.82e-06	0.000243	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GCLC—lung cancer	6.82e-06	0.000243	CbGpPWpGaD
Capecitabine—Hypersensitivity—Etoposide—lung cancer	6.82e-06	0.000105	CcSEcCtD
Capecitabine—DPYD—Metabolism—PTGS2—lung cancer	6.8e-06	0.000242	CbGpPWpGaD
Capecitabine—Erythema—Methotrexate—lung cancer	6.79e-06	0.000105	CcSEcCtD
Capecitabine—Malnutrition—Methotrexate—lung cancer	6.79e-06	0.000105	CcSEcCtD
Capecitabine—Haemoglobin—Doxorubicin—lung cancer	6.79e-06	0.000105	CcSEcCtD
Capecitabine—Headache—Gemcitabine—lung cancer	6.79e-06	0.000105	CcSEcCtD
Capecitabine—Rhinitis—Doxorubicin—lung cancer	6.77e-06	0.000104	CcSEcCtD
Capecitabine—Dyspepsia—Docetaxel—lung cancer	6.77e-06	0.000104	CcSEcCtD
Capecitabine—Hepatitis—Doxorubicin—lung cancer	6.76e-06	0.000104	CcSEcCtD
Capecitabine—Haemorrhage—Doxorubicin—lung cancer	6.76e-06	0.000104	CcSEcCtD
Capecitabine—Hypoaesthesia—Doxorubicin—lung cancer	6.72e-06	0.000104	CcSEcCtD
Capecitabine—Pharyngitis—Doxorubicin—lung cancer	6.71e-06	0.000103	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	6.7e-06	0.000239	CbGpPWpGaD
Capecitabine—Decreased appetite—Docetaxel—lung cancer	6.69e-06	0.000103	CcSEcCtD
Capecitabine—Hypersensitivity—Paclitaxel—lung cancer	6.69e-06	0.000103	CcSEcCtD
Capecitabine—Urinary tract disorder—Doxorubicin—lung cancer	6.67e-06	0.000103	CcSEcCtD
Capecitabine—Oedema peripheral—Doxorubicin—lung cancer	6.66e-06	0.000103	CcSEcCtD
Capecitabine—Dysgeusia—Methotrexate—lung cancer	6.65e-06	0.000103	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Docetaxel—lung cancer	6.64e-06	0.000102	CcSEcCtD
Capecitabine—Asthenia—Etoposide—lung cancer	6.64e-06	0.000102	CcSEcCtD
Capecitabine—Connective tissue disorder—Doxorubicin—lung cancer	6.64e-06	0.000102	CcSEcCtD
Capecitabine—Fatigue—Docetaxel—lung cancer	6.63e-06	0.000102	CcSEcCtD
Capecitabine—Urethral disorder—Doxorubicin—lung cancer	6.62e-06	0.000102	CcSEcCtD
Capecitabine—Nausea—Irinotecan—lung cancer	6.61e-06	0.000102	CcSEcCtD
Capecitabine—Constipation—Docetaxel—lung cancer	6.58e-06	0.000101	CcSEcCtD
Capecitabine—Pain—Docetaxel—lung cancer	6.58e-06	0.000101	CcSEcCtD
Capecitabine—Back pain—Methotrexate—lung cancer	6.57e-06	0.000101	CcSEcCtD
Capecitabine—Pruritus—Etoposide—lung cancer	6.55e-06	0.000101	CcSEcCtD
Capecitabine—Visual impairment—Doxorubicin—lung cancer	6.51e-06	0.0001	CcSEcCtD
Capecitabine—Asthenia—Paclitaxel—lung cancer	6.51e-06	0.0001	CcSEcCtD
Capecitabine—TYMS—Metabolism—ENO1—lung cancer	6.47e-06	0.000231	CbGpPWpGaD
Capecitabine—Nausea—Gemcitabine—lung cancer	6.44e-06	9.93e-05	CcSEcCtD
Capecitabine—Vomiting—Cisplatin—lung cancer	6.42e-06	9.91e-05	CcSEcCtD
Capecitabine—Pruritus—Paclitaxel—lung cancer	6.42e-06	9.9e-05	CcSEcCtD
Capecitabine—Vision blurred—Methotrexate—lung cancer	6.4e-06	9.87e-05	CcSEcCtD
Capecitabine—Erythema multiforme—Doxorubicin—lung cancer	6.39e-06	9.85e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CG—lung cancer	6.38e-06	0.000228	CbGpPWpGaD
Capecitabine—Rash—Cisplatin—lung cancer	6.37e-06	9.83e-05	CcSEcCtD
Capecitabine—Dermatitis—Cisplatin—lung cancer	6.36e-06	9.82e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Docetaxel—lung cancer	6.34e-06	9.78e-05	CcSEcCtD
Capecitabine—Diarrhoea—Etoposide—lung cancer	6.33e-06	9.77e-05	CcSEcCtD
Capecitabine—Eye disorder—Doxorubicin—lung cancer	6.31e-06	9.74e-05	CcSEcCtD
Capecitabine—Ill-defined disorder—Methotrexate—lung cancer	6.3e-06	9.72e-05	CcSEcCtD
Capecitabine—Tinnitus—Doxorubicin—lung cancer	6.3e-06	9.72e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Docetaxel—lung cancer	6.29e-06	9.7e-05	CcSEcCtD
Capecitabine—Anaemia—Methotrexate—lung cancer	6.28e-06	9.68e-05	CcSEcCtD
Capecitabine—Cardiac disorder—Doxorubicin—lung cancer	6.27e-06	9.67e-05	CcSEcCtD
Capecitabine—Flushing—Doxorubicin—lung cancer	6.27e-06	9.67e-05	CcSEcCtD
Capecitabine—Diarrhoea—Paclitaxel—lung cancer	6.21e-06	9.58e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—COL4A3BP—lung cancer	6.18e-06	0.00022	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AZIN2—lung cancer	6.18e-06	0.00022	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2A—lung cancer	6.17e-06	0.00022	CbGpPWpGaD
Capecitabine—Angiopathy—Doxorubicin—lung cancer	6.13e-06	9.46e-05	CcSEcCtD
Capecitabine—Malaise—Methotrexate—lung cancer	6.13e-06	9.45e-05	CcSEcCtD
Capecitabine—Dizziness—Etoposide—lung cancer	6.12e-06	9.44e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—PIK3CB—lung cancer	6.12e-06	0.000218	CbGpPWpGaD
Capecitabine—Immune system disorder—Doxorubicin—lung cancer	6.1e-06	9.41e-05	CcSEcCtD
Capecitabine—Vertigo—Methotrexate—lung cancer	6.1e-06	9.41e-05	CcSEcCtD
Capecitabine—Mediastinal disorder—Doxorubicin—lung cancer	6.09e-06	9.39e-05	CcSEcCtD
Capecitabine—Body temperature increased—Docetaxel—lung cancer	6.08e-06	9.38e-05	CcSEcCtD
Capecitabine—Abdominal pain—Docetaxel—lung cancer	6.08e-06	9.38e-05	CcSEcCtD
Capecitabine—Leukopenia—Methotrexate—lung cancer	6.08e-06	9.38e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—POMC—lung cancer	6.07e-06	0.000217	CbGpPWpGaD
Capecitabine—Chills—Doxorubicin—lung cancer	6.06e-06	9.35e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—PTGS2—lung cancer	6.06e-06	0.000216	CbGpPWpGaD
Capecitabine—Arrhythmia—Doxorubicin—lung cancer	6.04e-06	9.31e-05	CcSEcCtD
Capecitabine—Dizziness—Paclitaxel—lung cancer	6e-06	9.26e-05	CcSEcCtD
Capecitabine—Nausea—Cisplatin—lung cancer	6e-06	9.26e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—MDM2—lung cancer	5.98e-06	0.000213	CbGpPWpGaD
Capecitabine—Alopecia—Doxorubicin—lung cancer	5.97e-06	9.21e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—PTEN—lung cancer	5.93e-06	0.000211	CbGpPWpGaD
Capecitabine—Cough—Methotrexate—lung cancer	5.93e-06	9.14e-05	CcSEcCtD
Capecitabine—Mental disorder—Doxorubicin—lung cancer	5.92e-06	9.13e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—CREBBP—lung cancer	5.92e-06	0.000211	CbGpPWpGaD
Capecitabine—Vomiting—Etoposide—lung cancer	5.88e-06	9.08e-05	CcSEcCtD
Capecitabine—Malnutrition—Doxorubicin—lung cancer	5.88e-06	9.07e-05	CcSEcCtD
Capecitabine—Erythema—Doxorubicin—lung cancer	5.88e-06	9.07e-05	CcSEcCtD
Capecitabine—Rash—Etoposide—lung cancer	5.84e-06	9e-05	CcSEcCtD
Capecitabine—Dermatitis—Etoposide—lung cancer	5.83e-06	8.99e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—lung cancer	5.83e-06	0.000208	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP2E1—lung cancer	5.8e-06	0.000207	CbGpPWpGaD
Capecitabine—Headache—Etoposide—lung cancer	5.8e-06	8.94e-05	CcSEcCtD
Capecitabine—Flatulence—Doxorubicin—lung cancer	5.8e-06	8.94e-05	CcSEcCtD
Capecitabine—Chest pain—Methotrexate—lung cancer	5.78e-06	8.92e-05	CcSEcCtD
Capecitabine—Arthralgia—Methotrexate—lung cancer	5.78e-06	8.92e-05	CcSEcCtD
Capecitabine—Myalgia—Methotrexate—lung cancer	5.78e-06	8.92e-05	CcSEcCtD
Capecitabine—Vomiting—Paclitaxel—lung cancer	5.77e-06	8.9e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	5.76e-06	0.000205	CbGpPWpGaD
Capecitabine—Dysgeusia—Doxorubicin—lung cancer	5.76e-06	8.88e-05	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.74e-06	8.86e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—NQO1—lung cancer	5.74e-06	0.000205	CbGpPWpGaD
Capecitabine—Rash—Paclitaxel—lung cancer	5.72e-06	8.83e-05	CcSEcCtD
Capecitabine—Dermatitis—Paclitaxel—lung cancer	5.72e-06	8.82e-05	CcSEcCtD
Capecitabine—Discomfort—Methotrexate—lung cancer	5.71e-06	8.81e-05	CcSEcCtD
Capecitabine—Back pain—Doxorubicin—lung cancer	5.69e-06	8.78e-05	CcSEcCtD
Capecitabine—Headache—Paclitaxel—lung cancer	5.68e-06	8.77e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Docetaxel—lung cancer	5.67e-06	8.74e-05	CcSEcCtD
Capecitabine—DPYD—Metabolism—EP300—lung cancer	5.65e-06	0.000202	CbGpPWpGaD
Capecitabine—Muscle spasms—Doxorubicin—lung cancer	5.65e-06	8.72e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—lung cancer	5.64e-06	0.000201	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CD—lung cancer	5.61e-06	0.0002	CbGpPWpGaD
Capecitabine—Confusional state—Methotrexate—lung cancer	5.59e-06	8.62e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	5.58e-06	0.000199	CbGpPWpGaD
Capecitabine—Vision blurred—Doxorubicin—lung cancer	5.54e-06	8.55e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—ALB—lung cancer	5.54e-06	0.000197	CbGpPWpGaD
Capecitabine—Asthenia—Docetaxel—lung cancer	5.52e-06	8.51e-05	CcSEcCtD
Capecitabine—Infection—Methotrexate—lung cancer	5.51e-06	8.5e-05	CcSEcCtD
Capecitabine—Nausea—Etoposide—lung cancer	5.5e-06	8.48e-05	CcSEcCtD
Capecitabine—Ill-defined disorder—Doxorubicin—lung cancer	5.46e-06	8.42e-05	CcSEcCtD
Capecitabine—Pruritus—Docetaxel—lung cancer	5.44e-06	8.39e-05	CcSEcCtD
Capecitabine—Nervous system disorder—Methotrexate—lung cancer	5.44e-06	8.39e-05	CcSEcCtD
Capecitabine—Anaemia—Doxorubicin—lung cancer	5.44e-06	8.39e-05	CcSEcCtD
Capecitabine—Thrombocytopenia—Methotrexate—lung cancer	5.43e-06	8.37e-05	CcSEcCtD
Capecitabine—Nausea—Paclitaxel—lung cancer	5.39e-06	8.31e-05	CcSEcCtD
Capecitabine—Skin disorder—Methotrexate—lung cancer	5.38e-06	8.31e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—EP300—lung cancer	5.37e-06	0.000191	CbGpPWpGaD
Capecitabine—Hyperhidrosis—Methotrexate—lung cancer	5.36e-06	8.27e-05	CcSEcCtD
Capecitabine—Malaise—Doxorubicin—lung cancer	5.3e-06	8.18e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—PTEN—lung cancer	5.29e-06	0.000188	CbGpPWpGaD
Capecitabine—Vertigo—Doxorubicin—lung cancer	5.28e-06	8.15e-05	CcSEcCtD
Capecitabine—Anorexia—Methotrexate—lung cancer	5.28e-06	8.15e-05	CcSEcCtD
Capecitabine—Syncope—Doxorubicin—lung cancer	5.27e-06	8.14e-05	CcSEcCtD
Capecitabine—Leukopenia—Doxorubicin—lung cancer	5.26e-06	8.12e-05	CcSEcCtD
Capecitabine—Diarrhoea—Docetaxel—lung cancer	5.26e-06	8.12e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—ATP5H—lung cancer	5.25e-06	0.000187	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—POMC—lung cancer	5.24e-06	0.000187	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND1—lung cancer	5.21e-06	0.000186	CbGpPWpGaD
Capecitabine—Palpitations—Doxorubicin—lung cancer	5.2e-06	8.02e-05	CcSEcCtD
Capecitabine—Hypotension—Methotrexate—lung cancer	5.18e-06	7.99e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—STK11—lung cancer	5.17e-06	0.000184	CbGpPWpGaD
Capecitabine—Loss of consciousness—Doxorubicin—lung cancer	5.17e-06	7.97e-05	CcSEcCtD
Capecitabine—Cough—Doxorubicin—lung cancer	5.13e-06	7.92e-05	CcSEcCtD
Capecitabine—Dizziness—Docetaxel—lung cancer	5.09e-06	7.85e-05	CcSEcCtD
Capecitabine—Hypertension—Doxorubicin—lung cancer	5.08e-06	7.83e-05	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Methotrexate—lung cancer	5.05e-06	7.79e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDKN1A—lung cancer	5.04e-06	0.00018	CbGpPWpGaD
Capecitabine—CDA—Metabolism—EP300—lung cancer	5.04e-06	0.00018	CbGpPWpGaD
Capecitabine—Insomnia—Methotrexate—lung cancer	5.01e-06	7.73e-05	CcSEcCtD
Capecitabine—Myalgia—Doxorubicin—lung cancer	5.01e-06	7.72e-05	CcSEcCtD
Capecitabine—Chest pain—Doxorubicin—lung cancer	5.01e-06	7.72e-05	CcSEcCtD
Capecitabine—Arthralgia—Doxorubicin—lung cancer	5.01e-06	7.72e-05	CcSEcCtD
Capecitabine—Anxiety—Doxorubicin—lung cancer	4.99e-06	7.7e-05	CcSEcCtD
Capecitabine—Paraesthesia—Methotrexate—lung cancer	4.98e-06	7.68e-05	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.97e-06	7.67e-05	CcSEcCtD
Capecitabine—Discomfort—Doxorubicin—lung cancer	4.95e-06	7.63e-05	CcSEcCtD
Capecitabine—Dyspnoea—Methotrexate—lung cancer	4.94e-06	7.62e-05	CcSEcCtD
Capecitabine—Dry mouth—Doxorubicin—lung cancer	4.9e-06	7.55e-05	CcSEcCtD
Capecitabine—Vomiting—Docetaxel—lung cancer	4.89e-06	7.54e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CB—lung cancer	4.89e-06	0.000174	CbGpPWpGaD
Capecitabine—Dyspepsia—Methotrexate—lung cancer	4.88e-06	7.53e-05	CcSEcCtD
Capecitabine—Rash—Docetaxel—lung cancer	4.85e-06	7.48e-05	CcSEcCtD
Capecitabine—Dermatitis—Docetaxel—lung cancer	4.85e-06	7.47e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PTGS2—lung cancer	4.84e-06	0.000173	CbGpPWpGaD
Capecitabine—Confusional state—Doxorubicin—lung cancer	4.84e-06	7.47e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.83e-06	0.000172	CbGpPWpGaD
Capecitabine—Decreased appetite—Methotrexate—lung cancer	4.82e-06	7.43e-05	CcSEcCtD
Capecitabine—Headache—Docetaxel—lung cancer	4.82e-06	7.43e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK3—lung cancer	4.81e-06	0.000171	CbGpPWpGaD
Capecitabine—Oedema—Doxorubicin—lung cancer	4.8e-06	7.4e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—EP300—lung cancer	4.8e-06	0.000171	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Methotrexate—lung cancer	4.79e-06	7.38e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—GSTP1—lung cancer	4.78e-06	0.000171	CbGpPWpGaD
Capecitabine—Fatigue—Methotrexate—lung cancer	4.78e-06	7.37e-05	CcSEcCtD
Capecitabine—Infection—Doxorubicin—lung cancer	4.77e-06	7.36e-05	CcSEcCtD
Capecitabine—Pain—Methotrexate—lung cancer	4.74e-06	7.31e-05	CcSEcCtD
Capecitabine—Shock—Doxorubicin—lung cancer	4.72e-06	7.29e-05	CcSEcCtD
Capecitabine—Nervous system disorder—Doxorubicin—lung cancer	4.71e-06	7.26e-05	CcSEcCtD
Capecitabine—Thrombocytopenia—Doxorubicin—lung cancer	4.7e-06	7.25e-05	CcSEcCtD
Capecitabine—Tachycardia—Doxorubicin—lung cancer	4.68e-06	7.23e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—PLBD1—lung cancer	4.68e-06	0.000167	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—lung cancer	4.68e-06	0.000167	CbGpPWpGaD
Capecitabine—Skin disorder—Doxorubicin—lung cancer	4.66e-06	7.19e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CAT—lung cancer	4.66e-06	0.000166	CbGpPWpGaD
Capecitabine—Hyperhidrosis—Doxorubicin—lung cancer	4.64e-06	7.16e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	4.61e-06	0.000164	CbGpPWpGaD
Capecitabine—Anorexia—Doxorubicin—lung cancer	4.58e-06	7.06e-05	CcSEcCtD
Capecitabine—Nausea—Docetaxel—lung cancer	4.57e-06	7.05e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Methotrexate—lung cancer	4.57e-06	7.05e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Methotrexate—lung cancer	4.53e-06	6.99e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—ABCB1—lung cancer	4.53e-06	0.000161	CbGpPWpGaD
Capecitabine—Hypotension—Doxorubicin—lung cancer	4.49e-06	6.92e-05	CcSEcCtD
Capecitabine—Urticaria—Methotrexate—lung cancer	4.4e-06	6.79e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—GSTM1—lung cancer	4.4e-06	0.000157	CbGpPWpGaD
Capecitabine—Body temperature increased—Methotrexate—lung cancer	4.38e-06	6.76e-05	CcSEcCtD
Capecitabine—Abdominal pain—Methotrexate—lung cancer	4.38e-06	6.76e-05	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.37e-06	6.75e-05	CcSEcCtD
Capecitabine—Insomnia—Doxorubicin—lung cancer	4.34e-06	6.7e-05	CcSEcCtD
Capecitabine—Paraesthesia—Doxorubicin—lung cancer	4.31e-06	6.65e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—MAPK3—lung cancer	4.3e-06	0.000153	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HSD17B10—lung cancer	4.28e-06	0.000153	CbGpPWpGaD
Capecitabine—Dyspnoea—Doxorubicin—lung cancer	4.28e-06	6.6e-05	CcSEcCtD
Capecitabine—Dyspepsia—Doxorubicin—lung cancer	4.23e-06	6.52e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PTEN—lung cancer	4.23e-06	0.000151	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CA—lung cancer	4.18e-06	0.000149	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MYC—lung cancer	4.18e-06	0.000149	CbGpPWpGaD
Capecitabine—Decreased appetite—Doxorubicin—lung cancer	4.17e-06	6.44e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CYP1A1—lung cancer	4.17e-06	0.000149	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Doxorubicin—lung cancer	4.14e-06	6.39e-05	CcSEcCtD
Capecitabine—Fatigue—Doxorubicin—lung cancer	4.14e-06	6.38e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—ERCC2—lung cancer	4.13e-06	0.000147	CbGpPWpGaD
Capecitabine—Constipation—Doxorubicin—lung cancer	4.1e-06	6.33e-05	CcSEcCtD
Capecitabine—Pain—Doxorubicin—lung cancer	4.1e-06	6.33e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Methotrexate—lung cancer	4.08e-06	6.3e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—EP300—lung cancer	4.03e-06	0.000144	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CKB—lung cancer	3.98e-06	0.000142	CbGpPWpGaD
Capecitabine—Asthenia—Methotrexate—lung cancer	3.98e-06	6.14e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Doxorubicin—lung cancer	3.96e-06	6.1e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Doxorubicin—lung cancer	3.93e-06	6.06e-05	CcSEcCtD
Capecitabine—Pruritus—Methotrexate—lung cancer	3.92e-06	6.05e-05	CcSEcCtD
Capecitabine—Urticaria—Doxorubicin—lung cancer	3.81e-06	5.88e-05	CcSEcCtD
Capecitabine—Abdominal pain—Doxorubicin—lung cancer	3.79e-06	5.85e-05	CcSEcCtD
Capecitabine—Body temperature increased—Doxorubicin—lung cancer	3.79e-06	5.85e-05	CcSEcCtD
Capecitabine—Diarrhoea—Methotrexate—lung cancer	3.79e-06	5.85e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CNDP2—lung cancer	3.74e-06	0.000134	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM2—lung cancer	3.74e-06	0.000134	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CA—lung cancer	3.73e-06	0.000133	CbGpPWpGaD
Capecitabine—Dizziness—Methotrexate—lung cancer	3.67e-06	5.65e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—MTMR3—lung cancer	3.64e-06	0.00013	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOA1—lung cancer	3.58e-06	0.000128	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PGAM1—lung cancer	3.55e-06	0.000127	CbGpPWpGaD
Capecitabine—Hypersensitivity—Doxorubicin—lung cancer	3.54e-06	5.46e-05	CcSEcCtD
Capecitabine—Vomiting—Methotrexate—lung cancer	3.52e-06	5.44e-05	CcSEcCtD
Capecitabine—Rash—Methotrexate—lung cancer	3.5e-06	5.39e-05	CcSEcCtD
Capecitabine—Dermatitis—Methotrexate—lung cancer	3.49e-06	5.39e-05	CcSEcCtD
Capecitabine—Headache—Methotrexate—lung cancer	3.47e-06	5.36e-05	CcSEcCtD
Capecitabine—Asthenia—Doxorubicin—lung cancer	3.44e-06	5.31e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—TP53—lung cancer	3.43e-06	0.000122	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—lung cancer	3.42e-06	0.000122	CbGpPWpGaD
Capecitabine—Pruritus—Doxorubicin—lung cancer	3.4e-06	5.24e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—CYP2A7—lung cancer	3.39e-06	0.000121	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SDC4—lung cancer	3.31e-06	0.000118	CbGpPWpGaD
Capecitabine—Nausea—Methotrexate—lung cancer	3.29e-06	5.08e-05	CcSEcCtD
Capecitabine—Diarrhoea—Doxorubicin—lung cancer	3.28e-06	5.07e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—PIK3CG—lung cancer	3.26e-06	0.000116	CbGpPWpGaD
Capecitabine—Dizziness—Doxorubicin—lung cancer	3.17e-06	4.9e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—POMC—lung cancer	3.11e-06	0.000111	CbGpPWpGaD
Capecitabine—Vomiting—Doxorubicin—lung cancer	3.05e-06	4.71e-05	CcSEcCtD
Capecitabine—CDA—Metabolism—AKT1—lung cancer	3.05e-06	0.000109	CbGpPWpGaD
Capecitabine—Rash—Doxorubicin—lung cancer	3.03e-06	4.67e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—CREBBP—lung cancer	3.03e-06	0.000108	CbGpPWpGaD
Capecitabine—Dermatitis—Doxorubicin—lung cancer	3.02e-06	4.66e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—RRM1—lung cancer	3.02e-06	0.000108	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA3—lung cancer	3.02e-06	0.000108	CbGpPWpGaD
Capecitabine—Headache—Doxorubicin—lung cancer	3.01e-06	4.64e-05	CcSEcCtD
Capecitabine—TYMP—Metabolism—PIK3CA—lung cancer	2.98e-06	0.000106	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CD—lung cancer	2.87e-06	0.000102	CbGpPWpGaD
Capecitabine—Nausea—Doxorubicin—lung cancer	2.85e-06	4.4e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—B4GALT5—lung cancer	2.84e-06	0.000101	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALB—lung cancer	2.83e-06	0.000101	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA4—lung cancer	2.76e-06	9.84e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.7e-06	9.62e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA2—lung cancer	2.69e-06	9.59e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTA1—lung cancer	2.59e-06	9.25e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCC3—lung cancer	2.57e-06	9.15e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CB—lung cancer	2.5e-06	8.92e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKR1C1—lung cancer	2.48e-06	8.86e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—lung cancer	2.48e-06	8.84e-05	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—lung cancer	2.43e-06	8.68e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—UGT1A1—lung cancer	2.41e-06	8.6e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GNG11—lung cancer	2.33e-06	8.3e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.31e-06	8.25e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALDOA—lung cancer	2.21e-06	7.9e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTEN—lung cancer	2.16e-06	7.71e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NCOA3—lung cancer	2.15e-06	7.67e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.11e-06	7.53e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCG2—lung cancer	2.09e-06	7.46e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ADCY1—lung cancer	2.09e-06	7.46e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—EP300—lung cancer	2.06e-06	7.35e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HPGDS—lung cancer	2.05e-06	7.31e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ENO2—lung cancer	2.05e-06	7.31e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPP2R1B—lung cancer	2.04e-06	7.27e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.01e-06	7.17e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTT1—lung cancer	1.99e-06	7.09e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP2A6—lung cancer	1.97e-06	7.01e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GCLC—lung cancer	1.97e-06	7.01e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.96e-06	6.99e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ENO1—lung cancer	1.86e-06	6.65e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.86e-06	6.62e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.83e-06	6.54e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP2E1—lung cancer	1.67e-06	5.96e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NQO1—lung cancer	1.65e-06	5.9e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.62e-06	5.77e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.6e-06	5.72e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—lung cancer	1.52e-06	5.44e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—STK11—lung cancer	1.49e-06	5.31e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.4e-06	4.99e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTP1—lung cancer	1.38e-06	4.92e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CAT—lung cancer	1.34e-06	4.79e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.33e-06	4.76e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCB1—lung cancer	1.31e-06	4.66e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TYMS—lung cancer	1.28e-06	4.57e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—lung cancer	1.27e-06	4.52e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—lung cancer	1.25e-06	4.44e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1A1—lung cancer	1.2e-06	4.28e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ERCC2—lung cancer	1.19e-06	4.25e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOA1—lung cancer	1.03e-06	3.68e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.87e-07	3.52e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CG—lung cancer	9.41e-07	3.36e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—POMC—lung cancer	8.96e-07	3.19e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CREBBP—lung cancer	8.72e-07	3.11e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CD—lung cancer	8.27e-07	2.95e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—lung cancer	8.17e-07	2.91e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CB—lung cancer	7.21e-07	2.57e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—lung cancer	7.14e-07	2.55e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTEN—lung cancer	6.23e-07	2.22e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—EP300—lung cancer	5.94e-07	2.12e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—lung cancer	4.4e-07	1.57e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—lung cancer	3.59e-07	1.28e-05	CbGpPWpGaD
